285 related articles for article (PubMed ID: 34286886)
61. Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.
Abidogun TM; Cole TO; Massey E; Kleinman M; Greenblatt AD; Seitz-Brown CJ; Magidson JF; Belcher AM
J Subst Use Addict Treat; 2023 Feb; 145():208946. PubMed ID: 36880915
[TBL] [Abstract][Full Text] [Related]
62. Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.
McNeil R; Kerr T; Anderson S; Maher L; Keewatin C; Milloy MJ; Wood E; Small W
Soc Sci Med; 2015 May; 133():168-76. PubMed ID: 25875323
[TBL] [Abstract][Full Text] [Related]
63. Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial.
Cochran G; Shen J; Cox N; Field C; Carlston K; Sengpraseut B; White A; Okifuji A; Jackman C; Haaland B; Ragsdale R; Gordon AJ; Tarter R
Contemp Clin Trials; 2022 May; 116():106759. PubMed ID: 35417771
[TBL] [Abstract][Full Text] [Related]
64. Methadone related deaths compared to all prescription related deaths.
Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
[TBL] [Abstract][Full Text] [Related]
65. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
66. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.
Glenn MC; Sohler NL; Starrels JL; Maradiaga J; Jost JJ; Arnsten JH; Cunningham CO
Subst Abus; 2016; 37(3):387-391. PubMed ID: 26731299
[TBL] [Abstract][Full Text] [Related]
67. Medication-assisted treatment with methadone: assessing the evidence.
Fullerton CA; Kim M; Thomas CP; Lyman DR; Montejano LB; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
Psychiatr Serv; 2014 Feb; 65(2):146-57. PubMed ID: 24248468
[TBL] [Abstract][Full Text] [Related]
68. Concurrent drug use among methadone maintenance patients in mountainous areas in northern Vietnam.
Tran BX; Boggiano VL; Thi Nguyen HL; Nguyen LH; Nguyen HV; Hoang CD; Le HT; Tran TD; Le HQ; Latkin CA; Thi Vu TM; Zhang MW; Ho RC
BMJ Open; 2018 Mar; 8(3):e015875. PubMed ID: 29567839
[TBL] [Abstract][Full Text] [Related]
69. Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction).
Suen LW; Incze M; Simon C; Englander H; Bratberg J; Groves Scott G; Winograd R
Subst Use Addctn J; 2024 Jul; 45(3):337-345. PubMed ID: 38804606
[TBL] [Abstract][Full Text] [Related]
70. 'Red Flags' and 'Red Tape': Telehealth and pharmacy-level barriers to buprenorphine in the United States.
Textor L; Ventricelli D; Aronowitz SV
Int J Drug Policy; 2022 Jul; 105():103703. PubMed ID: 35561484
[TBL] [Abstract][Full Text] [Related]
71. Characteristics and current clinical practices of opioid treatment programs in the United States.
Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
[TBL] [Abstract][Full Text] [Related]
72. Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences.
Zielinski L; Bhatt M; Sanger N; Plater C; Worster A; Varenbut M; Daiter J; Pare G; Marsh DC; Desai D; MacKillop J; Steiner M; McDermid Vaz S; Thabane L; Samaan Z
Biol Sex Differ; 2017; 8():8. PubMed ID: 28367308
[TBL] [Abstract][Full Text] [Related]
73. COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania.
Kawasaki SS; Zimmerman R; Shen C; Zgierska AE
J Subst Use Addict Treat; 2023 Dec; 155():209164. PubMed ID: 37730014
[TBL] [Abstract][Full Text] [Related]
74. Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario.
Guan Q; Sproule BA; Vigod SN; Cadarette SM; Greaves S; Martins D; Gomes T
Addiction; 2019 Feb; 114(2):268-277. PubMed ID: 30276907
[TBL] [Abstract][Full Text] [Related]
75. Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review.
Panwala V; Joudrey P; Kowalski M; Bach P; Amram O
J Subst Use Addict Treat; 2023 Sep; 152():209086. PubMed ID: 37270103
[TBL] [Abstract][Full Text] [Related]
76. Methadone maintenance in primary care: a randomized controlled trial.
Fiellin DA; O'Connor PG; Chawarski M; Pakes JP; Pantalon MV; Schottenfeld RS
JAMA; 2001 Oct; 286(14):1724-31. PubMed ID: 11594897
[TBL] [Abstract][Full Text] [Related]
77. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction.
Calcaterra SL; Bach P; Chadi A; Chadi N; Kimmel SD; Morford KL; Roy P; Samet JH
J Gen Intern Med; 2019 Jun; 34(6):1039-1042. PubMed ID: 30729416
[TBL] [Abstract][Full Text] [Related]
78. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
[TBL] [Abstract][Full Text] [Related]
79. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
80. Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.
Morozova O; Dvoryak S; Altice FL
Int J Drug Policy; 2013 Nov; 24(6):e91-8. PubMed ID: 24360402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
